Dusseldorf - Delayed Quote EUR
Cronos Group Inc (7CI.DU)
1.7390
+0.1440
+(9.03%)
As of 8:10:10 AM GMT+2. Market Open.
Loading Chart for 7CI.DU
- Previous Close
1.5950 - Open
1.7390 - Bid 1.7110 x --
- Ask 1.7800 x --
- Day's Range
1.7390 - 1.7390 - 52 Week Range
1.4250 - 2.7820 - Volume
0 - Avg. Volume
60 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 7CI.DU
View MorePerformance Overview: 7CI.DU
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
7CI.DU
4.66%
S&P/TSX Composite index (^GSPTSE)
2.57%
1-Year Return
7CI.DU
34.48%
S&P/TSX Composite index (^GSPTSE)
12.86%
3-Year Return
7CI.DU
35.62%
S&P/TSX Composite index (^GSPTSE)
26.27%
5-Year Return
7CI.DU
67.13%
S&P/TSX Composite index (^GSPTSE)
68.74%
Compare To: 7CI.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.20
-2.80%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1640
-2.68%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3850
-0.28%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2360
+0.85%
Mkt Cap EUR 76.786M
Industry Drug Manufacturers—Specialty & Generic
0.2140
-2.73%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1820
-2.96%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.18
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2340
+8.33%
Mkt Cap EUR 79.011M
Industry Drug Manufacturers—Specialty & Generic
0.4100
+6.69%
Mkt Cap EUR 423.665M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 7CI.DU
View MoreValuation Measures
As of 5/8/2025
Market Cap
679.88M
Enterprise Value
-77.99M
Trailing P/E
16.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.86
Price/Book (mrq)
0.65
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--